Christine Ring Insider Trades & Stock Holdings
Christine Ring, Chief Legal Officer at Nurix Therapeutics, Inc. has 2 Form 4 trades on file since Jun 25, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($580.44K), net -$580.44K. Latest filing: disposed of 28.93K shares of $NRIX on Jun 25, 2026 at $20.06.
- Trades on file
- 2
- Open-market bought
- $0
- Open-market sold
- $580.44K
- Net open-market
- -$580.44K
- Latest filing
- Jun 25, 2026
All insider trades by Christine Ring
| Date | Ticker | Type | Shares | Price | Value | Owned after | ΔOwn | 1W | 1M | 6M | Role | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $NRIX | Sell (Open-market sale) 10b5-1 | 28.93K | $20.06 | $580.44K | +6.7% | +4.3% | Chief Legal Officer | — | |||||
| $NRIX | Buy (Option exercise) | 28.93K | $8.05 | $232.85K | +6.7% | +4.3% | Chief Legal Officer | — |
"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.
Stocks Christine Ring traded
Frequently asked questions
Has Christine Ring been buying or selling stock?
Christine Ring has 0 open-market purchases and 1 open-market sale on file, net -$580.44K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.
What was Christine Ring's latest insider trade?
disposed of 28.93K shares of $NRIX on Jun 25, 2026 at $20.06.
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.